Abstract
We have examined the composition of the essential fatty acids in the plasma phospholipid fractions of 98 patients with histologically proven bladder cancer. These patients were attending hospital for regular follow-up by check cystoscopy. Patients were divided into two groups, depending on the cystoscopic findings, of either active (tumour recurrence seen) or inactive (no evidence of tumour recurrence) disease. Compared with a normal population, the plasma levels of most of the fatty acids, including arachidonic acid, were significantly lower in the 98 cancer patients (P less than 0.001, t-test). We were unable, however, to demonstrate any significant differences (Mann-Whitney U-test) between the active and inactive disease groups. Plasma levels of the essential fatty acids are abnormal in patients with bladder cancer; they do not help, however, to distinguish those patients with active disease from those with inactive disease. This may arise because the deficit in essential fatty acids we have demonstrated is a predisposing factor for the development of bladder cancer rather than a metabolic consequence of the tumour. Further studies are needed to establish the possible clinical role of measurement of essential fatty acids in patients with bladder carcinoma.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Brush M. G., Watson S. J., Horrobin D. F., Manku M. S. Abnormal essential fatty acid levels in plasma of women with premenstrual syndrome. Am J Obstet Gynecol. 1984 Oct 15;150(4):363–366. doi: 10.1016/s0002-9378(84)80139-8. [DOI] [PubMed] [Google Scholar]
- Horrobin D. F. The reversibility of cancer: the relevance of cyclic AMP, calcium, essential fatty acids and prostaglandin E1. Med Hypotheses. 1980 May;6(5):469–486. doi: 10.1016/0306-9877(80)90099-7. [DOI] [PubMed] [Google Scholar]
- Manku M. S., Horrobin D. F., Morse N. L., Wright S., Burton J. L. Essential fatty acids in the plasma phospholipids of patients with atopic eczema. Br J Dermatol. 1984 Jun;110(6):643–648. doi: 10.1111/j.1365-2133.1984.tb04698.x. [DOI] [PubMed] [Google Scholar]
- Miettinen T. A., Naukkarinen V., Huttunen J. K., Mattila S., Kumlin T. Fatty-acid composition of serum lipids predicts myocardial infarction. Br Med J (Clin Res Ed) 1982 Oct 9;285(6347):993–996. doi: 10.1136/bmj.285.6347.993. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Monis B., Eynard A. R. Abnormal cell proliferation and differentiation and urothelial tumorigenesis in essential fatty acid deficient (EFAD) rats. Prog Lipid Res. 1981;20:691–703. doi: 10.1016/0163-7827(81)90127-2. [DOI] [PubMed] [Google Scholar]
- Pretlow T. G., 2nd, Harris B. E., Bradley E. L., Jr, Bueschen A. J., Lloyd K. L., Pretlow T. P. Enzyme activities in prostatic carcinoma related to Gleason grades. Cancer Res. 1985 Jan;45(1):442–446. [PubMed] [Google Scholar]
- Reitz R. C., Thompson J. A., Morris H. P. Mitochondrial and microsomal phospholipids of Morris hepatoma 7777. Cancer Res. 1977 Feb;37(2):561–567. [PubMed] [Google Scholar]
- Weber G. Enzymology of cancer cells (first of two parts). N Engl J Med. 1977 Mar 3;296(9):486–492. doi: 10.1056/NEJM197703032960905. [DOI] [PubMed] [Google Scholar]
- von Houwelingen A. C., Kester A. D., Kromhout D., Hornstra G. Comparison between habitual intake of polyunsaturated fatty acids and their concentrations in serum lipid fractions. Eur J Clin Nutr. 1989 Jan;43(1):11–20. [PubMed] [Google Scholar]